Indab, Rogelio .
HRN: 25-05-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2024
CEFTRIAXONE 1G (VIAL)
05/17/2024
05/24/2024
IV
2g
OD
CAP-MR, UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes